Renal impairment in hepatic cryotherapy

被引:19
作者
Bagia, JS [1 ]
Perera, DS [1 ]
Morris, DL [1 ]
机构
[1] Univ New S Wales, St George Hosp, Dept Surg, Sydney, NSW 2217, Australia
关键词
hepatic cryotherapy; renal impairment; thrombocytopenia;
D O I
10.1006/cryo.1998.2085
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Cryoshock is a syndrome of coagulopathy, renal, and pulmonary injury following cryotherapy, and its etiology is unknown. The aim of this study was to assess the impact of hepatic cryotherapy on renal function, and whether this effect is related to volume of cryotherapy, and to identify any predictors of renal impairment in patients who undergo cryotherapy. A retrospective analysis of all patients with primary or secondary hepatic malignancy treated with cryotherapy from April 1990 to October 1996 was conducted. Ten of 204 patients with renal impairment (elevation in creatinine of greater than 0.02 mmol/L for more than 2 days postprocedure) were identified. One patient had postoperative pancreatitis with late renal impairment (20 days) and was excluded. The severity of renal impairment was usually modest (mean rise in creatinine of 0.31 mmol/L; SD, 0.19). Two patients required temporary hemodialysis. Only one patient, who had significant cardiac disease, had associated pulmonary injury and shock. Demographic data in both groups were comparable, except for a trend toward more noncolorectal cancer patients in the renal impairment group (4/9 vs 33/194). Patients in the renal impairment group had a greater number of lesions than those of the nonrenal impairment group (3.4 vs 2.1, P < 0.01), as well as larger lesion diameter (2.9 vs 1.9, P < 0.01), increased freezing time (74.7 vs 44.3, P < 0.01), and a higher aspartate transaminase (AST) (2254 vs 1157, P < 0.01). This study suggests that renal impairment is more likely to be seen in patients undergoing more extensive cryotherapy. The number and diameter of lesions together with AST data link renal injury with magnitude of liver injury-all renal impairment patients had an AST > 1000, compared with only 28% of patients who did not. (C) 1998 Academic Press.
引用
收藏
页码:263 / 267
页数:5
相关论文
共 16 条
[1]  
CADY B, 1992, ARCH SURG-CHICAGO, V127, P561
[2]   THROMBOCYTOPENIA AFTER HEPATIC CRYOTHERAPY FOR COLORECTAL METASTASES - CORRELATES WITH HEPATOCELLULAR INJURY [J].
COZZI, PJ ;
STEWART, GJ ;
MORRIS, DL .
WORLD JOURNAL OF SURGERY, 1994, 18 (05) :774-777
[3]  
COZZI PJ, 1995, CANCER, V76, P501, DOI 10.1002/1097-0142(19950801)76:3<501::AID-CNCR2820760322>3.0.CO
[4]  
2-X
[5]   ANESTHETIC EXPERIENCE WITH CRYOTHERAPY FOR TREATMENT OF HEPATIC MALIGNANCY [J].
GOODIE, DB ;
HORTON, MDA ;
MORRIS, RW ;
NAGY, LS ;
MORRIS, DL .
ANAESTHESIA AND INTENSIVE CARE, 1992, 20 (04) :491-496
[6]  
KOHN IJ, 1997, TECHNIQUES UROL, V24, P230
[7]  
MCCALL JL, 1995, BRIT J HOSP MED, V54, P378
[8]   TREATMENT OF HEPATIC METASTASES BY CRYOTHERAPY AND REGIONAL CYTOTOXIC PERFUSION [J].
MORRIS, DL ;
HORTON, MDA ;
DILLEY, AV ;
WARLTERS, A ;
CLINGAN, PR .
GUT, 1993, 34 (09) :1156-1157
[9]  
ONIK G, 1991, CANCER, V67, P901, DOI 10.1002/1097-0142(19910215)67:4<901::AID-CNCR2820670408>3.0.CO
[10]  
2-Z